A Study to Evaluate the Safety and Pharmacokinetics of OC-001 in Patients With Locally Advanced or Metastatic Cancers
Ocellaris Pharma, Inc.
Ocellaris Pharma, Inc.
Incyte Corporation
Actym Therapeutics, Inc.
Pfizer
University of Virginia
Telix Pharmaceuticals (Innovations) Pty Limited
Turnstone Biologics, Corp.
Seagen Inc.
Seagen Inc.
Sotio Biotech Inc.
Molecular Templates, Inc.
Merck Sharp & Dohme LLC
University of Florida
pharmaand GmbH
M.D. Anderson Cancer Center
Incyte Corporation
University of California, San Francisco
Cambridge University Hospitals NHS Foundation Trust
National Institutes of Health Clinical Center (CC)
CureOne
University Health Network, Toronto
BIND Therapeutics